InvestorsHub Logo
Followers 7
Posts 1112
Boards Moderated 0
Alias Born 11/14/2017

Re: None

Wednesday, 12/27/2017 8:32:37 AM

Wednesday, December 27, 2017 8:32:37 AM

Post# of 12427
MOVING FORWARD MIGHTLY! Lexington Biosciences, Inc. (CNSX:LNB.CN) (OTCQB:LXGTF) (the "Company" or "Lexington"), a development-stage medical device company, is pleased to announce entry into a strategic business relationship with a San Francisco arm of Navigant Consulting Inc., formerly Quorum Consulting. The intent of the relationship is to work with the relevant authorities towards developing a coverage policy in support of the planned commercial rollout of Lexington's HeartSentry endothelial function measurement product. Read this and more news for Lexington Biosciences at:

http://www.marketnewsupdates.com/news/lxgtf.html